Possible clinical applications for elevated glutathione levels Neurology Parkinsons disease Alzheimers disease Seizures Multiple sclerosis Eye diseases Cataracts Macular degeneration Glaucoma Cardiovascular Prevent heart disease Prevent stroke Prevent atherosclerosis Prevent reperfusion injury Digestive system Inflammatory bowel disease Hepatitis Malnutrition Pancreatitis Peptic Ulcer Toxicology Certain drug overdoses Tobacco smoke, auto exhaust Pollutants including heavy metals, pesticides Prevents hearing loss from noise pollution Detoxifies many well-known carcinomas Infectious disease and immunology Anti-viral (AIDS, hepatitis, herpes, common cold, etc.) Bacterial Infection Certain autoimmune dysfunction Chronic fatigue syndrome Immunosuppression Cancer Cancer prevention Suppress tumor growth Eliminate Carcinogens, mutagens Retard oxidative damage to DNA Prevent wasting disease Ease side effects of chemo- and radiotherapy Pulmonary Break up mucus (esp

These variations can impact enzymatic activity and binding affinities of the target isoform across different cohorts, raising concerns about the efficacy of inhibitors tailored to specific genetic profiles
Mechanistically, DOX stabilizes the copper importer SLC31A1 (CTR1) by inhibiting its proteasomal degradation and downregulating the copper efflux transporter ATPase Copper Transporting Beta (ATP7B), leading to a net increase in cellular copper [17, 76]
Disclaimer: This content is for educational purposes only and does not constitute medical advice
Sikiric, P., Udovicic, M., Barisic, I., Balenovic, D., Zivanovic Posilovic, G., Strinic, D., Uzun, S., Sikiric, S., Krezic, I., Zizek, H., Yago, H., Gojkovic, S., Smoday, I
Schulz V, Basu S, Freibert SA, Webert H, Boss L, Mhlenhoff U